½ÃÀ庸°í¼­
»óǰÄÚµå
1791931

¶óƾ¾Æ¸Þ¸®Ä«ÀÇ AI Áö¿ø ÀÇ·á ¿µ»ó ½ÃÀå

LATAM AI-assisted Medical Imaging Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Marketstrat, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 32 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ¸ÞŸµ¥ÀÌÅÍ

  • Áö¸®Àû ¹üÀ§ : ¶óƾ¾Æ¸Þ¸®Ä«(ºê¶óÁú, ¸ß½ÃÄÚ, Ä¥·¹, ÄÝ·Òºñ¾Æ, ¾Æ¸£ÇîÆ¼³ª, Æä·ç, Áß¹Ì, Ä«¸®ºêÇØ ±¹°¡ µî).
  • ÁÖ¿ä ¼öÄ¡(¶óƾ¾Æ¸Þ¸®Ä«) : 1¾ï 2,000¸¸ ´Þ·¯(2023³â) ¡æ 10¾ï ´Þ·¯(2032³â), CAGR-26.6%
  • ´ë»ó ºÎ¹® ¾ç½Ä(CT, MRI, X¼± ¹× DR, ÃÊÀ½ÆÄ, PET ¹× ÇÙ ÀÇÇÐ), ÀÓ»ó ºÐ¾ß(Á¾¾çÇÐ, ½Å°æÇÐ/³úÁ¹Áß, ½ÉÀå º´ÇÐ, È£Èí±â ¹× Æó, MSK ¹× Á¤Çü¿Ü°ú, ÀÏ¹Ý Áø´Ü), ¿ëµµ(Á¶±â ¹ß°ß ¹× ºÐ·ù, Áø´Ü Á¤È®µµ, ¿öÅ©ÇÃ·Î¿ì ¹× È¿À², ¿¹ÈÄ ¹× Ä¡·á, ¿µ»ó Çâ»ó ¹× ¿ë·®, ¼¼ºÐÈ­ ¹× Ư¡ ÃßÃâ, ¸ð´Þ¸®Æ¼ °£ ÅëÇÕ), ¼öÀÍ¿ø(Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º, Ŭ¶ó¿ìµå ¹× »ç¿ë´ç ÁöºÒ), ÃÖÁ¾ »ç¿ë(º´¿ø, ¿µ»ó ¼¾ÅÍ, Ŭ¸®´Ð, ¿ø°Ý ¹æ»ç¼±ÇÐ µî).
  • ÇÁ·¹ÀÓ¿öÅ© ¹× ºñÁÖ¾ó ¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º, »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º, GTM Áغñ ·¹ÀÌ´õ, GTM ŸÀÓ¶óÀÎ, Ŭ·¯½ºÅÍ ¿ì¼± ¼øÀ§ È÷Æ®¸Ê, ±ÔÁ¦ ¼Óµµ ¹× »óȯ ÆÞ½º, OEM AI ÀåÂø·ü.
  • Á¶»ç ¹æ¹ý ¹× ǰÁú º¸Áõ : µà¾ó ·»Áî(ž´Ù¿î ÆÛ³Î + »óÇâ½Ä ºÎÂø ¼Óµµ), Áõ°Å ½Å·Ú¼º ·çºê¸¯, ǰÁú°ü¸® ·çÇÁ(ÃÑ, ½ºÅ©·¡ÇÁ µðÇÁ, ½Å¼±µµ, ASP À§»ý).

¶óƾ¾Æ¸Þ¸®Ä«ÀÇ AI Áö¿ø ÀÇ·á ¿µ»ó ½ÃÀå(Markintel-TM Pulse)Àº ÀÌ Áö¿ª ¼ö¿ä ¡ÈÄ, ±ÔÁ¦ µ¿Çâ, ÀåÂø·üÀÇ °æÁ¦¼ºÀ» ÃßÃâÇÏ¿© ½ÇÇà °¡´ÉÇÑ GTM Ç÷¹À̺ÏÀ» ÀÛ¼ºÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí Áö¿ªº° ÇÁ·¹ÀÓ¿öÅ©, ±¹°¡º° Ŭ·¯½ºÅÍ ¿¹Ãø, ±Ù°Å¿¡ µû¸¥ ±ÇÀå »çÇ×À» ÀÌ¿ëÇÏ¿© ¾îµð¼­, ¾î¶»°Ô ÀÌ°Ü¾ß ÇÏ´ÂÁö¸¦ º¸¿©ÁÝ´Ï´Ù.

º» º¸°í¼­ÀÇ ´ë»óÀÚ

  • CT/MR/X¼± ¹øµé Á¦°ø ¹× ºÎÂø ¼Óµµ Àü·«À» °èȹÇϰí ÀÖ´Â À̹Ì¡ OEM ±â¾÷ .
  • ¿£ÅÍÇÁ¶óÀÌÁî ÆÄÀÏ·µ°ú À¯Åë¾÷ü ·çÆ®¸¦ ã´Â AI Ç»¾î Ç÷¹ÀÌ ¹× ¸¶ÄÏÇ÷¹À̽º ÅëÇÕ¾÷ü .
  • ¿öÅ©Ç÷οì/QA ¹× Ŭ¶ó¿ìµå OPEX¸¦ ÃÖÀûÈ­ÇÏ´Â ÅÚ·¹¶óµð¿À ·ÎÁö ³×Æ®¿öÅ© ¹× »ç¸³ º´¿ø ±×·ì .
  • ¼ºÀå Å׸¶ ¹× ÆÄÆ®³Ê ½ºÅ©¸®´×À» °ËÁõÇÏ´Â ÅõÀÚÀÚ ¹× ±â¾÷ °³¹ß.
  • °ø°ø ºÎ¹®ÀÇ ÇÁ·Î±×·¥ ¸®´õ(°áÇÙ, ³úÁ¹Áß, ½ºÅ©¸®´×).

¾òÀ» ¼ö ÀÖ´Â °Í : ¸Þ¸®Æ®

  • ÀλçÀÌÆ®¿¡¼­ ÇൿÀ¸·ÎÀÇ ¸íÈ®ÇÑ µµ¼± : ÀÌÁß ·»Áî ±â¼ú + QA ·çÇÁ´Â ¸ðµç Ç¥°¡ Áö¿ª ÇÕ°è·Î ±¼·¯°¡°í ¸ðµç ±ÇÀå »çÇ×À» Áõ°Å·Î ¸¸µì´Ï´Ù.
  • ¿ì¼±¼øÀ§°¡ ÁöÁ¤µÈ ±¹°¡º° Ŭ·¯½ºÅÍÀÇ ·Îµå¸ÊÀÔ´Ï´Ù .
  • ÇÁ·¹ÀÓ¿öÅ© ÁÖµµÀÇ GTM : ¼Ö·ç¼Ç µµÀÔ ¹× ¼ºÀå ¸ÅÆ®¸¯½º¿Í »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º´Â ½ÃÀå ±¸Á¶¸¦ ÆÄÆ®³Ê , °¡°Ý, Àü°³ ¿òÁ÷ÀÓÀ¸·Î º¯È¯ÇÕ´Ï´Ù.
  • ¿ÏÀüÇÑ ¼¼ºÐÈ­(¸ð´Þ¸®Æ¼, ÀÓ»ó ¿µ¿ª, ¿ëµµ, ¼öÀÍ¿ø, ÃÖÁ¾ ¿ëµµ)°ú 2023-2032³âÀÇ ¿¹Ãø¿¡ ÀÇÇØ »ç³» ÀÚ·á¿¡ÀÇ ½Å¼ÓÇÑ ÀçÀÌ¿ë °¡´É.

º¸°í¼­ ³»ºÎ : ¼½¼Çº° ÇÏÀ̶óÀÌÆ®

  • ¼½¼Ç 1 : 25ÃÊ ³»¿¡ ÀÐÀ» ¼ö ÀÖ´Â ÁÖ¿ä ¿ä¾à, Áö¿ª ¼öÁØÀÇ KPI, º¯°îÁ¡ ¹× ½Ã¼±, 12°³¿ù ÀÌ»çȸ ¼öÁØÀÇ ¾×¼Ç.
  • ¼½¼Ç 2 : Á¶»ç ±â¹ý-¹üÀ§, ¼¼ºÐÈ­, µà¾ó ·»Áî ¾ÆÅ°ÅØÃ³, Áõ°Å ½Å·Ú¼º, ǰÁúº¸Áõ .
  • ¼½¼Ç 3-4 : ½ÃÀå Ãß°è ¹× ¿¹Ãø-¼ºÀå µå¶óÀ̹ö ¿öÅÍÆú, ÅëÀÏ Å¬·¯½ºÅÍ ¸ðµ¨, Ŭ·¯½ºÅͺ° Ãß°è, ÀÓ»ó ¿µ¿ªº° Ãß°è, ¸ð´Þ¸®Æ¼º° Ãß°è, ¼öÀÍ Ãß°è, ¿ëµµº° Ãß°è, ÃÖÁ¾ ¿ëµµº° Ãß°è.
  • ¼½¼Ç 5-7 : GTM µµ±¸-¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º, »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º, 90ÀÏ ¿µ¾÷ ·Îµå¸Ê, GTM Áغñ ·¹ÀÌ´õ, ŸÀÓ¶óÀÎ, ±ÔÁ¦ ¼Óµµ, OEM ÀåÂø·ü, º¥´õ GTM ÇÏÀ̶óÀÌÆ®.

¸ñÂ÷

¼½¼Ç 1-ÁÖ¿ä ¿ä¾à

¼½¼Ç 2-Á¶»ç ±â¹ý

¼½¼Ç 3-¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®

  • ½ÃÀå ¿ä¾à
  • ¼ºÀå ÃËÁø¿äÀÎ ¿öÅÍÆú-¶óƾ¾Æ¸Þ¸®Ä«
  • Áö°æÇРŬ·¯½ºÅÍ(GTM Æ÷Ä¿½º¿ë)
  • ºÎ¹® µ¿Çâ(-2032³â)
  • ±ÔÁ¦ ½º³À¼¦(ºò5)
  • ÃֽŠÁ¤º¸(2024-2025³â)
  • Çൿ ÁöÇâ Ãßõ »çÇ×
  • »ó¾÷ ½ÅÈ£

¼½¼Ç 4-¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø

  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ±¹°¡º° Ŭ·¯½ºÅͺ°(2023-2032³â)
    • Ŭ·¯½ºÅÍ Å×À̺íÀ» Àд ¹æ¹ý
    • ¼ýÀÚ°¡ ÀǹÌÇÏ´Â °Í
    • Ŭ·¯½ºÅÍ °£ÀÇ ¿µÇâ(ÀÚ¿ø ÇÒ´ç ¹æ¹ý)
    • À§Çè°ú KPI ¿öÄ¡¸®½ºÆ®
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÀÓ»ó ¿µ¿ªº°(2023-2032³â)
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ¸ð´Þ¸®Æ¼º°(2023-2032³â)
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ¼öÀÍ¿øº°(2023-2032³â)
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÀÓ»ó ¿ëµµº°(2023-2032³â)
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÃÖÁ¾ ¿ëµµ Á¶Á÷º°(2023-2032³â)
  • ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : AI ±â¼úº°(2023-2032³â)

¼½¼Ç 5-MARKINTEL ¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º-¶óƾ¾Æ¸Þ¸®Ä«

  • »çºÐ¸é ºÐ¼®
  • Å©·Î½º Äõµå·±Æ® ¿î¿ë ·Îµå¸Ê

¼½¼Ç 6-MARKINTEL »ýŰè Çù¾÷ ¸ÅÆ®¸¯½º-¶óƾ¾Æ¸Þ¸®Ä«

  • »çºÐ¸é ºÐ¼®
  • ¿î¿ë ·Îµå¸Ê(90Àϰ£ ÁýÁß)
  • KPI ¿öÄ¡¸®½ºÆ®

¼½¼Ç 7-GTM °³¿ä-¶óƾ¾Æ¸Þ¸®Ä«

  • GTM Áغñ ·¹ÀÌ´õ-¶óƾ¾Æ¸Þ¸®Ä«
  • GTM ŸÀÓ¶óÀÎ-¶óƾ¾Æ¸Þ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡ Ŭ·¯½ºÅÍ ¿ä¾à
  • Ŭ·¯½ºÅÍ ¿ì¼±¼øÀ§ È÷Æ®¸Ê
  • ±ÔÁ¦ ¼Óµµ¿Í »óȯ µ¿Çâ-¶óƾ¾Æ¸Þ¸®Ä«
  • OEM AI ºÎÂøÀ²-¶óƾ¾Æ¸Þ¸®Ä«
  • ±â¾÷º° GTM ¼º¼÷µµ ÇÏÀ̶óÀÌÆ®-¶óƾ¾Æ¸Þ¸®Ä«
  • Á¶´Þ ¹× È£½ºÆÃ-Ŭ¶ó¿ìµå ¹× µ¥ÀÌÅÍ ·¹Áö´ø½Ã Äݾƿô
AJY 25.08.27

Report Metadata

  • Geographic scope: Latin America (Brazil; Mexico; Chile; Colombia; Argentina; Peru; Central America; Caribbean; other small states).
  • Key numbers (LATAM): $120M (2023) -> $1.0B (2032); CAGR ~26.6%.
  • Segmentation covered: Modalities (CT, MRI, X ray/DR, Ultrasound, PET/Nuclear); Clinical areas (Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic); Applications (Early detection/triage; Diagnostic accuracy; Workflow/efficiency; Prognosis/treatment; Image enhancement/dose; Segmentation/feature extraction; Integration across modalities); Revenue streams (Hardware; Software; Service; Cloud/Pay per Use); End use (Hospitals, Imaging centers, Clinics, Teleradiology, Other).
  • Frameworks & visuals included: Solution Adoption & Growth Matrix, Ecosystem Collaboration Matrix, GTM Readiness Radar, GTM Timeline, Cluster Priority Heatmap, Regulatory Velocity & Reimbursement Pulse, OEM AI Attach Rate.
  • Methodology & QA: Dual lens (top down funnel + bottom up attach rate), evidence confidence rubric, and QA loop (sum to total, scrape diff, freshness, ASP sanity).

The "LATAM - AI assisted Medical Imaging Market (Markintel-TM Pulse)" distills the region's demand signals, regulatory cadence, and attach rate economics into actionable GTM playbooks. It sizes the market and shows where-and how-to win using regional frameworks, country cluster forecasts, and evidence based recommendations.

Who should use this report:

  • Imaging OEMs planning bundled CT/MR/X ray offers and attach rate strategies.
  • AI pure plays & marketplace integrators seeking enterprise pilots and distributor routes.
  • Teleradiology networks & private hospital groups optimizing workflow/QA and cloud OPEX.
  • Investors & corporate development teams validating growth theses and partner screens.
  • Public sector program leads (TB, stroke, screening) aligning tenders to evidence and infrastructure.

What you get (benefits):

  • Clear line of sight from insight to action: dual lens methodology + QA loop ensure every table rolls to the regional total and every recommendation ties to evidence.
  • Prioritized country cluster roadmap with dollarized breakouts and 12 month actions.
  • Framework driven GTM: Solution Adoption & Growth Matrix and Ecosystem Collaboration Matrix translate market structure into partner, pricing, and deployment moves.
  • Full segmentation (modality, clinical area, application, revenue stream, end use) with 2023-2032 forecasts for quick reuse in internal decks.

Inside the report (highlights by section):

  • Section 1: Executive Summary-the 25 second read; region level KPIs; inflection points & watch outs; 12 month board level actions.
  • Section 2: Research Methodology-scope, segmentation, dual lens architecture, evidence confidence, and QA.
  • Section 3-4: Market Analysis & Forecasts-growth driver waterfall; unified cluster model; estimates by cluster, clinical area, modality, revenue stream, application, end use.
  • Sections 5-7: GTM Tools-Solution Adoption & Growth Matrix; Ecosystem Collaboration Matrix; 90 day operating roadmap; GTM Readiness Radar; Timeline; regulatory velocity; OEM attach rate; vendor GTM highlights.

TABLE OF CONTENTS

SECTION 1 - EXECUTIVE SUMMARY

  • Why LATAM Matters - The 25 second Read
  • LATAM Outlook at a Glance (2023 -> 2032)
  • Where Growth Concentrates - Modality & Clinical Mix (LATAM)
  • Inflection Points & Watchouts - LATAM
  • Competitive Heat - the Moves to Track (LATAM Lens)
  • 12-Month Board-Level Actions (What to Do Now)

SECTION 2 - RESEARCH METHODOLOGY

  • About This Pulse Report
  • Scope & Segmentation
  • Marketstrat "Insights -> Action"
  • Dual lens Architecture (Regionalized)
  • Evidence Confidence - LATAM
  • Quality Assurance Loop
  • Limitations & Mitigations (Regional)
  • Regulatory & Privacy References Used in Sizing and GTM Guidance

SECTION 3 - LATIN AMERICAN (LATAM) MARKET ANALYSIS

  • Market Summary
  • Growth Driver Waterfall - LATAM
  • Geo-Economic Clusters (for GTM Focus)
  • Segment Trends to 2032
  • Regulatory Snapshot (Big 5)
  • What's New for 2024-25
  • Action-Oriented Recommendations
  • Commercial Signals

SECTION 4 - LATAM MARKET ESTIMATES & FORECASTS

  • LATAM Market by Country Cluster (2023-2032)
    • How to Read the Cluster Table
    • What the Numbers Imply
    • Cross Cluster Implications (How to Allocate Resources)
    • Risk & KPI Watchlist
  • LATAM Market by Clinical Area (2023-2032)
  • LATAM Market by Modality (2023-2032)
  • LATAM Market by Revenue Stream (2023-2032)
  • LATAM Market by Clinical Application (2023-2032)
  • LATAM Market by End-Use Organization (2023-2032)
  • LATAM Market by AI Technology (2023-2032)

SECTION 5 - MARKINTEL SOLUTION ADOPTION & GROWTH MATRIX - LATAM

  • Quadrants Analysis
  • Cross-Quadrant Operating Roadmap (2024 27)

SECTION 6 - MARKINTEL ECOSYSTEM COLLABORATION MATRIX - LATAM

  • Quadrants Analysis
  • Operating Roadmap (90 Day Focus)
  • KPI Watchlist

SECTION 7 - GTM AT-A-GLANCE - LATAM

  • GTM Readiness Radar - LATAM
  • GTM Timeline - LATAM
  • LATAM Country Clusters Summary
  • Cluster-Priority Heatmap
  • Regulatory Velocity & Reimbursement Pulse - LATAM
  • OEM AI Attach Rate - LATAM
  • GTM Maturity Highlights by Company - LATAM
  • Procurement & Hosting - Cloud/Data Residency Callout
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦